Sanders Capital, LLC Gilead Sciences, Inc. Transaction History

Sanders Capital, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 28, 2020	SELL	$62.63 - $80.22 $714 Million - $914 Million	-11,392,884 Closed	0 $0
Q4 2019 Jan 30, 2020	BUY	$61.62 - $67.78 $12 Million - $13.2 Million	194,791 Added 1.74%	11,392,884 $813 Million
Q3 2019 Nov 13, 2019	SELL	$62.51 - $69.0 $20.5 Million - $22.6 Million	-327,940 Reduced 2.85%	11,198,093 $771 Million
Q2 2019 Jul 23, 2019	BUY	$61.87 - $69.38 $14.5 Million - $16.2 Million	234,100 Added 2.07%	11,526,033 $842 Million
Q1 2019 May 01, 2019	BUY	$62.53 - $70.05 $33.8 Million - $37.8 Million	539,793 Added 5.02%	11,291,933 $794 Million
Q4 2018 Jan 29, 2019	BUY	$60.54 - $79.0 $14.3 Million - $18.7 Million	236,540 Added 2.25%	10,752,140 $729 Million
Q3 2018 Oct 29, 2018	SELL	$71.28 - $78.92 $4.56 Million - $5.05 Million	-63,975 Reduced 0.6%	10,515,600 $876 Million
Q2 2018 Jul 24, 2018	BUY	$64.88 - $75.68 $45.2 Million - $52.7 Million	696,200 Added 7.04%	10,579,575 $804 Million
Q1 2018 May 14, 2018	SELL	$72.84 - $88.8 $1.98 Million - $2.41 Million	-27,118 Reduced 0.27%	9,883,375 $796 Million
Q4 2017 Jan 31, 2018	BUY	$71.15 - $83.52 $358 Million - $420 Million	5,026,015 Added 102.9%	9,910,493 $757 Million
Q1 2017 May 24, 2022	BUY	N/A	4,884,478	4,884,478 $0

1,926

992M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $118B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Sanders Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Sanders Capital, LLC with notifications on news.